TRODELVY INF.COZ. TOZ 200MG 50ML IV FLK.

How does it work? TRODELVY contains the active ingredient sacituzumab govitecan-hziy, which is an antibody-drug conjugate (ADC). It works by targeting and binding to a protein called Trop-2, which is often found in high levels on the surface of certain cancer cells, including those in metastatic triple-negative breast cancer (mTNBC). Once bound to the cancer cells, TRODELVY releases a chemotherapy drug payload, irinotecan, which helps in killing the cancer cells. What are the benefits? The benefits of TRODELVY include: Treatment of Metastatic Triple-Negative Breast Cancer (mTNBC): TRODELVY is indicated for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease. It may help in slowing down the progression of the disease and improving survival rates. Improved Response Rates: Clinical studies have shown that TRODELVY can lead to higher response rates compared to standard chemotherapy regimens in patients with metastatic triple-negative breast cancer. How should I take? TRODELVY is administered intravenously (IV) by a healthcare professional in a clinic or hospital setting. The dosage and frequency of administration will be determined by your healthcare provider based on factors such as your overall health, the stage of your cancer, and your response to treatment. It’s essential to strictly adhere to the recommended dosing schedule and follow-up appointments as directed by your doctor. Who can take? TRODELVY is intended for adult patients diagnosed with metastatic triple-negative breast cancer who have previously received at least two prior therapies for metastatic disease. It’s crucial to consult with an oncologist or healthcare provider to determine if TRODELVY is suitable for your specific medical condition and treatment history. Where can I buy? TRODELVY is a prescription medication and can be obtained from hospitals, oncology clinics, or specialty pharmacies with a valid prescription from a healthcare provider. It’s not available over the counter and requires administration by a qualified healthcare professional. HTML Table 1: Prices of TRODELVY INF.COZ. TOZ 200MG 50ML IV FLK. in different countries html Copy code

Country	Price (USD)
United States	$7,000
United Kingdom	£6,200
Canada	$8,500
Australia	$9,800
India	₹40,000

Prices may vary depending on factors such as location, healthcare provider, and insurance coverage. It’s advisable to consult with your healthcare provider for accurate pricing information and assistance in obtaining your medication.